"The weight loss drug Orlistat is slated to go on sale in European pharmacies without the requirement of a prescription within the next few months. Although early approval was first given several months ago in October 2008, the European Commission has just now given the go ahead for public distribution of the anti-obesity drug, which will be marketed under the name Alli by GlaxoSmithKline, the makers of the product. The estimated price for Alli is GBP1.50 a day." - eCanadaNow
No comments:
Post a Comment